Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Pemphigus vulgaris ȯÀÚÀÇ Àü½Å ¹× ±¸°­Áõ»ó ¹ßÇö¿¡ °üÇÑ Áõ·Êº¸°í

Systemic and Oral Manifestation of Pemphigus vulgaris

´ëÇѱ¸°­³»°úÇÐȸÁö 2002³â 27±Ç 4È£ p.453 ~ 457
¼Ò¼Ó »ó¼¼Á¤º¸
±Çº´±â/Kwon BK ¾ÈÇüÁØ/±èÀçÈ«/ÃÖÁ¾ÈÆ/±èÁ¾¿­/Ahn HJ/Kim JH/Choi JH/Kim CY

Abstract


Pemphigus vulgaris is a serious autoimmune disease that forms blisters on mucosa and skin. It is common in people over 60 years of age, and it has a strong genetic tendency. Autoantibodies can be found in intercelluar spaces between epithelial cells, and because of the autoantibodies for desmosomes, desmosomes that connect the squamous epithelial cells are destroyed. In pemphigus vulgaris, oral lesion is almost always present, and it is often present before skin lesions. Oral lesions can be present anywhere in the oral cavity including the mucosa and gingiva. When it is present in the gingiva, it is in a form of desquamative gingivitis. In severe cases, the entire oral mucosa is involved, and various stages of vesicle formation are manifested. In addition, although the treatment of pemphigus vulgaris is relatively successful, the oral lesion is the last to disappear, and periodic deterioration and alleviation of symptoms is common.
Definite diagnosis for pempigus vulgaris is based on microscopic examinations including direct immunofluorescence. As in most autoimmune diseases, immunosuppressive drugs are used for treatment. The prognosis should be made carefully considering its chronic progression and side effects of long-term medications. With early diagnosis and appropriate treatment during the initial stage of pemphigus vulgaris, wide skin involvement can be controlled, and need for aggressive treatment with undesirable side effects can be reduced.
In this case report, the continuous treatment of a patient with pemphigus vulgaris was observed in consultation with a dermatologist, and a general investigation of pemphigus vulgaris is made.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI